Is type 2 diabetes an adiposity-based metabolic disease? From the origin of insulin resistance to the concept of dysfunctional adipose tissue.

Abstract

In the last decades of the past century, a remarkable amount of research efforts, money and hopes was generated to unveil the basis of insulin resistance that was believed to be the primary etiological factor in the development of type 2 diabetes. From the Reaven's insulin resistance syndrome to the DeFronzo's triumvirate (skeletal muscle, liver and beta-cell) and to Kahn's discovery (among many others) of insulin receptor downregulation and autophosphorylation, an enthusiastic age of metabolic in vivo and in vitro research took place, making the promise of a resolutory ending. However, from many published data (those of insulin receptoropathies and lipodystrophies, the genome-wide association studies results, the data on reversibility of type 2 diabetes after bariatric surgery or very-low-calorie diets, and many others) it appears that insulin resistance is not a primary defect but it develops secondarily to increased fat mass. In particular, it develops from a mismatch between the surplus caloric intake and the storage capacity of adipose tissue. On this basis, we propose to change the today's definition of type 2 diabetes in adiposity-based diabetes.Level of Evidence as a narrative review a vast array of studies have been included in the analysis, ranging from properly designed randomized controlled trials to case studies; however, the overall conclusion may be regarded as level IV.

• Authors: Paolo Sbraccia, Monica D'Adamo, Valeria Guglielmi
• Journal: Eating and weight disorders : EWD (Eat Weight Disord) Vol. 26 Issue 8 Pg. 2429-2441 (Dec 2021) ISSN: 1590-1262 [Electronic] Germany
• PMID: 33555509 (Publication Type: Journal Article, Review)
• Copyright: © 2021. The Author(s).

Topics

• Adipose Tissue
• Adiposity
• Diabetes Mellitus, Type 2
• Genome-Wide Association Study
• Humans
• Insulin Resistance